Press Releases
Search
-
21 Apr 2021
bioMérieux - First Quarter 2011 Business Review
Marcy L'Etoile, France - April 21, 2011. Sales growth: 3.5% like-for-like Strong momentum in North America Temporary slowdown in China and India Robust growth in clinical microbiology 2011 sales growt...
-
07 Apr 2021
bioMérieux announces the CE marking of 3 dengue immunoassays on VIDAS®
bioMérieux, a world leader in the field of in vitro diagnostics, announces the CE marking of its innovative and fully-automated assays to diagnose dengue infection: VIDAS® DENGUE NS1 Ag VIDAS® Anti-DE...
-
24 Mar 2021
bioMérieux announces the CE marking of TB IGRA® test on VIDAS®
Today marks World Tuberculosis (TB) Day and bioMérieux, a world leader in the field of in vitro diagnostics, announces the CE marking of its innovative and fully-automated test VIDAS® TB IGRA (Interfe...
-
18 Mar 2021
BIOFIRE® Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 obtains De Novo FDA Authorization
Marcy l’Étoile (France) – bioMérieux, a world leader in the field of in vitro diagnostics, today announced that BioFire Diagnostics, its subsidiary specialized in molecular syndromic infectious diseas...
-
09 Mar 2021
The Biotech Digital Campus joins forces with biotechnology schools and training organizations to develop the talents of tomorrow
An unprecedented alliance serving the French bioproduction sector "Recipient of a Future Investment Program award" The Biotech Digital Campus is a recipient of the Engineering Action for innovative pr...
-
24 Feb 2021
bioMérieux – 2020 Financial Results
€3,118 million in full-year 2020 sales, up 19.7 % like-for-like Robust sales performance in the fourth quarter, with organic growth of 20.5 % led by sales of molecular biology reagents Contributive op...